Medpace Holdings (MEDP) Receivables (2015 - 2026)

Medpace Holdings (MEDP) has reported Receivables for 12 consecutive years, with $418.8 million the latest figure, recorded in Q1 2026.

• Receivables for Q1 2026 came in at $418.8 million, up 37.51% year-over-year; the trailing twelve-month figure through Mar 2026 was $418.8 million (up 37.51% YoY), and the FY2025 annual result was $427.4 million, up 41.63% from the prior year.
• Receivables was $418.8 million for Q1 2026 at Medpace Holdings, down from $427.4 million in the prior quarter.
• Over five years, Receivables peaked at $427.4 million in Q4 2025 and troughed at $225.9 million in Q2 2022.
• Average Receivables over 5 years is $321.5 million, with a median of $306.7 million recorded in 2023.
• Year-over-year, Receivables jumped 55.73% in 2022 and decreased 5.95% in 2024.
• Over 5 years, Receivables stood at $293.8 million in 2022, then increased by 9.21% to $320.9 million in 2023, then dropped by 5.95% to $301.8 million in 2024, then soared by 41.63% to $427.4 million in 2025, then slipped by 2.02% to $418.8 million in 2026.
• Per Business Quant data, the three most recent Receivables figures were $418.8 million in Q1 2026, $427.4 million in Q4 2025, and $383.8 million in Q3 2025.